Shigeru Iwazaki Selected Research

FR 128998

1/2001

FR128998 (a PAF Receptor Antagonist) Counters the Increased Pulmonary Vascular Resistance Associated with Ischemia-Reperfusion Injury in the Canine Lung.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeru Iwazaki Research Topics

Disease

3	Stomach Neoplasms (Stomach Cancer) 12/2011 - 03/2005
2	Reperfusion Injury 01/2003 - 01/2001
1	Ascites 12/2011
1	Ischemia 01/2003
1	Flushing 02/2002
1	Necrosis 02/2002

Drug/Important Bio-Agent (IBA)

3	doxifluridineIBA 12/2011 - 03/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2011 - 03/2005
1	Interleukin-1 (Interleukin 1)IBA 01/2003
1	FR 167653IBA 01/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003
1	Alanine Transaminase (SGPT)IBA 02/2002
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2002
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2002
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2002
1	CelsiorIBA 02/2002
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2002
1	FR 128998IBA 01/2001

Therapy/Procedure

2	Warm Ischemia 01/2003 - 01/2001
1	Drug Therapy (Chemotherapy) 12/2011
1	Combination Drug Therapy (Combination Chemotherapy) 01/2011
1	Lung Transplantation 01/2001